We genotyped this mutation and other known variants in HOXB13 in 2,443 hereditary prostate cancer families recruited by members of the International Consortium for Prostate Cancer Genetics (ICPCG), a large NCI-funded collaborative resource for studies of genetic susceptibility for hereditary prostate cancer. The gene discussed is HOXB13; the disease is prostate carcinoma.